Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shortened Regimens for First Diagnosed Smear Positive Drug Susceptible Pulmonary Tuberculosis: a Randomised Controlled Non-inferiority Trial

NCT02901288 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT02901288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shortened Regimens for First Diagnosed Smear Positive Drug Susceptible Pulmonary Tuberculosis: a Randomised Controlled Non-inferiority Trial
Lead sponsor
Beijing Chest Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2016
Completion date
December 31, 2018
Enrollment
3,900 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary